Status:
COMPLETED
Enhanced and Attendance-based Prize CM in Community Settings
Lead Sponsor:
UConn Health
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine Dependence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to address the conditions under which prize contingency management (CM) for abstinence and attendance may improve outcomes of cocaine-dependent patients. For patients who...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Current DSM-IV diagnosis of cocaine dependence
- A cocaine-positive urine sample submitted during the first two scheduled treatment days at the center
- Willing to provide names, addresses and phone numbers of individuals to assist in locating the patient for follow-up evaluations
- English speaking
- Willing to sign informed consent.
Exclusion
- Serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk)
- Dementia (\<23 on the Mini Mental State Exam; Folstein et al. 1975)
- In recovery from pathological gambling
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
443 Patients enrolled
Trial Details
Trial ID
NCT00606853
Start Date
October 1 2003
End Date
April 1 2009
Last Update
April 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UConn Health Center
Farmington, Connecticut, United States, 06030